Patent · US Active

Ester prodrugs of prostratin and related phorbol compounds

US8431612B2 · kind B2 · utility

2Cited by
14References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2011
Grant dateApr 30, 2013
Priority date—
Expiry dateJun 21, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/86
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure provides analogs and derivatives of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.